PrEP Education for HIV Prevention

(PrEPSchool Trial)

The trial aims to increase awareness and access to PrEP, a medication that helps prevent HIV, through peer educators. It focuses on reducing stigma and discrimination while improving knowledge about PrEP among African American college students. Participants will attend educational sessions to bridge gaps in understanding and using PrEP. Eligible participants are English-speaking, HIV-negative students, aged 18-26, enrolled at Spelman College, Morehouse College, Clark Atlanta University, or Morehouse School of Medicine, and not currently using PrEP. As an unphased trial, this study offers participants the chance to contribute to important research that could enhance community health and awareness.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research shows that programs teaching about PrEP (pre-exposure prophylaxis) are generally safe for participants. These programs aim to increase understanding of PrEP, a medication that helps prevent HIV. The studies focus on education rather than safety in the usual sense because no medications or medical procedures are involved in this educational trial. The main goal is to teach and reduce stigma around using PrEP.

Researchers are excited about the PrEP Awareness and Uptake Educational Program because it targets the social barriers to HIV prevention, such as stigma and lack of knowledge. Unlike standard medical treatments like antiretroviral therapy or the daily PrEP pill, this program focuses on educating African American college students through peer-led sessions. This approach not only aims to increase awareness and reduce discrimination around PrEP use but also empowers participants to make informed decisions about their health. By addressing cultural and social factors, this educational intervention could significantly boost PrEP uptake and effectively prevent HIV in high-risk communities.

Research has shown that PrEP, a medication taken before exposure to HIV, can reduce the risk of infection by up to 99% when used correctly. However, despite widespread awareness of PrEP, many people do not use it. Studies have found that educational programs can increase both awareness and use of PrEP. This trial's educational intervention focuses on reducing stigma and improving knowledge about PrEP, particularly among African American college students. By enhancing understanding and accessibility of PrEP, this program aims to play a crucial role in preventing HIV.¹³⁵⁶⁷